(Q37774375)

23 August 2017

1 reference

title

Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice (English)

1 reference

23 August 2017

1 reference

Angel Lanas

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

20 July 2010

1 reference

Expert Opinion on Drug Safety

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

45-54

1 reference

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Aspirin for the primary prevention of stroke and myocardial infarction: ineffective or wrong dose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Nonsteroidal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Predictors of gastroduodenal erosions in patients taking low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Aspirin and folic acid for the prevention of recurrent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Aspirin dose and duration of use and risk of colorectal cancer in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

Aspirin use and survival after diagnosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2010.507629

10.1517/14740338.2010.507629

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jgsencllezb57avpbpx6a3os6u

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_jgsencllezb57avpbpx6a3os6u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jgsencllezb57avpbpx6a3os6u

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/jgsencllezb57avpbpx6a3os6u

1 reference